Primary Bone and Soft Tissue Tumors: Nuclear Medicine in Current Algorithms; [Primer Kemik ve Yumuşak Doku Tümörleri: Güncel Algoritmalarda Nükleer Tıp]

The main purpose of evaluating musculoskeletal system (MSS) tumors is diagnosis and staging, and these tumors require a multidisciplinary approach. The role of fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and bone scintigraphy in the initial evaluation of incidentally detected bone lesions on magnetic resonance (MR) imaging and CT and primary bone tumors is limited. In cases where clinical or radiographic findings are considered suspicious or additional anatomical data are required; Advanced imaging modalities such as CT, MR and nuclear medicine examinations play a complementary role in the diagnosis and treatment of primary MSS tumors. The advantage of nuclear medicine examinations over radiography or MRI is the capacity to scan the whole body; it can be used for standard staging, restaging, and evaluation of therapeutic response. In addition, PET/MR appears to have strong potential in soft tissue sarcoma staging and bone marrow evaluation. © Telif Hakkı 2022 Türkiye Nükleer Tıp Derneği